Position in BTAIQ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$18
+$1 QoQ
Shares Held
13
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 47 holders
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BTAIQ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $10,808,957 across 45 Drug Manufacturers - Specialty & Generic names. BTAIQ ranks #43 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
143,876 | $4,874,518 | |
| 2 | ETST |
Earth Science Tech, Inc.
|
96,054 | $3,857,528 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,544 | $836,585 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
3,008 | $506,968 | |
| 5 | ZTS |
Zoetis Inc.
|
2,994 | $215,148 | |
| 6 | LQDA |
Liquidia Corp
|
950 | $75,743 | |
| 7 | CTOR |
Citius Oncology, Inc.
|
107,424 | $69,825 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
447 | $49,590 |
All Filings in BTAIQ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18 | 13 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $17 | 13 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $6,992 | 4,370 | Shares | Sole | 2026-02-06 | |
| 2021-06-30 | — | 0 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | — | 3 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | — | 1 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | — | 1 | Shares | Sole | 2020-10-29 | |
| No filing history on record for this holder in this stock. | ||||||